Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Sanofi (SNY) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$8.03B
Net Income	$492.41M
Cost of Goods Sold	$2.39B
Gross Profit	$5.64B
Operating Expenses	$6.98B
Operating Income	$1.05B
Non-Operating Income/Expense	$-619.28M
Pre-Tax Income	$434.52M
Normalized Pre-Tax Income	$904.64M
Income after Taxes	$442.13M
Income from Continuous Operations	$435.61M
Consolidated Net Income/Loss	$504.87M
Normalized Income after Taxes	$1.00B
EBIT	$1.05B
EBITDA	$1.05B
Weighted-Average Shares Outstanding (Basic)	2.50B
Weighted-Average Shares Outstanding (Diluted)	2.51B
Earnings per Share (EPS) (Basic)	$0.19
Earnings per Share (EPS) (Diluted)	$0.19
Balance Sheet Financials
Current Assets	$46.08B
Property, Plant, and Equipment	$10.92B
Long-Term Assets	$97.62B
Total Assets	$143.70B
Current Liabilities	$31.56B
Long-Term Debt	$12.76B
Long-Term Liabilities	$27.90B
Total Liabilities	$59.45B
Common Equity	$84.25B
Tangible Shareholders Equity	$12.82B
Shareholders Equity	$84.25B
Common Shares Outstanding	2.53B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.83B
Cash Flow from Investing Activities	$-4.77B
Cash Flow from Financial Activities	$-6.24B
Beginning Cash	$9.43B
End Cash	$8.05B
Increase/Decrease in Cash	$-1.37B
Stock-Based Compensation	--
Common Stock Dividends Paid	$-5.13B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.46
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.21
Gross Margin	70.22%
Operating Margin	13.13%
EBIT Margin	13.13%
EBITDA Margin	--
Pre-Tax Profit Margin	5.41%
Profit Margin	6.13%
Free Cash Flow	$7.95B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.23
Receiveable Turnover	0.88
Days Sales in Receivables	101.90
Return on Equity	0.52%
Return on Tangible Equity	3.40%
Return on Assets	0.30%
Return on Investments	0.45%
Book Value Per Share	$33.35
Free Cash Flow per Share	$3.16
Operating Cash Flow per Share	$3.91

Data from Zacks Investment Research, Inc.